Ventricular Assist Device Therapy Normalizes Inducible Nitric Oxide Synthase Expression and Reduces Cardiomyocyte Apoptosis in the Failing Human Heart
- 3 May 2005
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 45 (9) , 1419-1424
- https://doi.org/10.1016/j.jacc.2004.05.090
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cardiomyocyte apoptosis and progression of heart failure to transplantationEuropean Journal of Clinical Investigation, 1999
- NITRIC OXIDE IN THE FAILING MYOCARDIUMCardiology Clinics, 1998
- Heterogeneous Expression and Activity of Endothelial and Inducible Nitric Oxide Synthases in End-Stage Human Heart FailureCirculation, 1998
- Implantable Left Ventricular Assist Devices Provide an Excellent Outpatient Bridge to Transplantation and RecoveryJournal of the American College of Cardiology, 1997
- Nitric Oxide Synthases and Cardiac MuscleArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Exercise Capacity Recovers Slowly But Fully in Patients With a Left Ventricular Assist DevicePublished by Wolters Kluwer Health ,1996
- Endothelial Nitric Oxide Synthase Targeting to CaveolaeJournal of Biological Chemistry, 1996
- Expression of Inducible Nitric Oxide Synthase in Human Heart FailureCirculation, 1996
- The epidemiology of heart failure: The Framingham StudyJournal of the American College of Cardiology, 1993
- Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.Circulation, 1990